Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study

Glomerulonephritis

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency Empagliflozin in Patients With Glomerulonephritis Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis Trial to Evaluate the Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE) US Time-Harmonic Elastography for the Early Detection of Childhood Glomerulonephritis Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive ANCA-associated Glomerulonephritis Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy Plant Versus Animal Dietary Protein and the Effect on Proteinuria Cyclophosphamide and Fludarabine to Treat Lupus Nephritis Immune System Related Kidney Disease Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease A Proof of Concept Study for 6 Month Treatment in Patients With C3 Glomerulopathy (C3G) Mesenchymal Stromal Cells (MSC´s) in Renal Lupus Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G or IC-MPGN Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study A Proof of Concept Study for a 12 Month Treatment in Patients With C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN) Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis Recurrent Glomerulonephritis After Renal Transplantation Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis